Logo image of HUM

HUMANA INC (HUM) Stock Fundamental Analysis

NYSE:HUM - New York Stock Exchange, Inc. - US4448591028 - Common Stock - Currency: USD

286.39  +5.05 (+1.79%)

After market: 290.788 +4.4 (+1.54%)

Fundamental Rating

4

Overall HUM gets a fundamental rating of 4 out of 10. We evaluated HUM against 104 industry peers in the Health Care Providers & Services industry. HUM has a medium profitability rating, but doesn't score so well on its financial health evaluation. HUM has a decent growth rate and is not valued too expensively. HUM also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HUM was profitable.
In the past year HUM had a positive cash flow from operations.
HUM had positive earnings in each of the past 5 years.
In the past 5 years HUM always reported a positive cash flow from operatings.
HUM Yearly Net Income VS EBIT VS OCF VS FCFHUM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

With a decent Return On Assets value of 3.13%, HUM is doing good in the industry, outperforming 67.31% of the companies in the same industry.
The Return On Equity of HUM (8.64%) is better than 71.15% of its industry peers.
HUM has a Return On Invested Capital of 6.01%. This is in the better half of the industry: HUM outperforms 64.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HUM is in line with the industry average of 9.36%.
Industry RankSector Rank
ROA 3.13%
ROE 8.64%
ROIC 6.01%
ROA(3y)4.8%
ROA(5y)6.13%
ROE(3y)13.67%
ROE(5y)16.75%
ROIC(3y)7.86%
ROIC(5y)8.6%
HUM Yearly ROA, ROE, ROICHUM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of HUM (1.28%) is comparable to the rest of the industry.
HUM's Profit Margin has declined in the last couple of years.
HUM has a Operating Margin (2.87%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of HUM has declined.
Industry RankSector Rank
OM 2.87%
PM (TTM) 1.28%
GM N/A
OM growth 3Y-13.15%
OM growth 5Y-12.08%
PM growth 3Y-33.79%
PM growth 5Y-24.48%
GM growth 3YN/A
GM growth 5YN/A
HUM Yearly Profit, Operating, Gross MarginsHUM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HUM is creating some value.
HUM has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HUM has less shares outstanding
The debt/assets ratio for HUM is higher compared to a year ago.
HUM Yearly Shares OutstandingHUM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
HUM Yearly Total Debt VS Total AssetsHUM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

HUM has a debt to FCF ratio of 5.16. This is a neutral value as HUM would need 5.16 years to pay back of all of its debts.
The Debt to FCF ratio of HUM (5.16) is better than 67.31% of its industry peers.
HUM has a Debt/Equity ratio of 0.69. This is a neutral value indicating HUM is somewhat dependend on debt financing.
The Debt to Equity ratio of HUM (0.69) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 5.16
Altman-Z N/A
ROIC/WACC0.77
WACC7.79%
HUM Yearly LT Debt VS Equity VS FCFHUM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HUM Yearly Current Assets VS Current LiabilitesHUM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for HUM have decreased by -9.19% in the last year.
The Earnings Per Share has been decreasing by -1.92% on average over the past years.
The Revenue has grown by 9.88% in the past year. This is quite good.
The Revenue has been growing by 12.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.19%
EPS 3Y-7.76%
EPS 5Y-1.92%
EPS Q2Q%-9.91%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y12.34%
Revenue growth 5Y12.66%
Sales Q2Q%10.24%

3.2 Future

The Earnings Per Share is expected to grow by 16.81% on average over the next years. This is quite good.
HUM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.89% yearly.
EPS Next Y2.09%
EPS Next 2Y-6.25%
EPS Next 3Y10.57%
EPS Next 5Y16.81%
Revenue Next Year8.3%
Revenue Next 2Y5.57%
Revenue Next 3Y6.28%
Revenue Next 5Y7.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HUM Yearly Revenue VS EstimatesHUM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
HUM Yearly EPS VS EstimatesHUM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.43, the valuation of HUM can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of HUM indicates a rather cheap valuation: HUM is cheaper than 80.77% of the companies listed in the same industry.
HUM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.87.
Based on the Price/Forward Earnings ratio of 20.13, the valuation of HUM can be described as rather expensive.
60.58% of the companies in the same industry are more expensive than HUM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, HUM is valued a bit cheaper.
Industry RankSector Rank
PE 14.43
Fwd PE 20.13
HUM Price Earnings VS Forward Price EarningsHUM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

69.23% of the companies in the same industry are more expensive than HUM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HUM indicates a somewhat cheap valuation: HUM is cheaper than 79.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.17
EV/EBITDA 9.7
HUM Per share dataHUM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800 1K

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)6.91
PEG (5Y)N/A
EPS Next 2Y-6.25%
EPS Next 3Y10.57%

7

5. Dividend

5.1 Amount

HUM has a Yearly Dividend Yield of 1.26%.
HUM's Dividend Yield is rather good when compared to the industry average which is at 2.92. HUM pays more dividend than 85.58% of the companies in the same industry.
With a Dividend Yield of 1.26, HUM pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

The dividend of HUM is nicely growing with an annual growth rate of 10.32%!
HUM has been paying a dividend for at least 10 years, so it has a reliable track record.
As HUM did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)10.32%
Div Incr Years0
Div Non Decr Years8
HUM Yearly Dividends per shareHUM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

27.22% of the earnings are spent on dividend by HUM. This is a low number and sustainable payout ratio.
The dividend of HUM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP27.22%
EPS Next 2Y-6.25%
EPS Next 3Y10.57%
HUM Yearly Income VS Free CF VS DividendHUM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
HUM Dividend Payout.HUM Dividend Payout, showing the Payout Ratio.HUM Dividend Payout.PayoutRetained Earnings

HUMANA INC

NYSE:HUM (8/15/2025, 8:27:27 PM)

After market: 290.788 +4.4 (+1.54%)

286.39

+5.05 (+1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners98.06%
Inst Owner Change-1.23%
Ins Owners0.13%
Ins Owner Change4.92%
Market Cap34.56B
Analysts70.32
Price Target294.65 (2.88%)
Short Float %3.55%
Short Ratio2.44
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend3.55
Dividend Growth(5Y)10.32%
DP27.22%
Div Incr Years0
Div Non Decr Years8
Ex-Date06-27 2025-06-27 (0.885)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.37%
Min EPS beat(2)4.86%
Max EPS beat(2)13.88%
EPS beat(4)4
Avg EPS beat(4)10.23%
Min EPS beat(4)1.21%
Max EPS beat(4)20.98%
EPS beat(8)7
Avg EPS beat(8)-11.27%
EPS beat(12)11
Avg EPS beat(12)-5.94%
EPS beat(16)15
Avg EPS beat(16)-2.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.39%
Min Revenue beat(2)-1.32%
Max Revenue beat(2)0.55%
Revenue beat(4)3
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.32%
Max Revenue beat(4)1.18%
Revenue beat(8)6
Avg Revenue beat(8)0.48%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)7
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.66%
PT rev (3m)-5.43%
EPS NQ rev (1m)15.74%
EPS NQ rev (3m)-8.57%
EPS NY rev (1m)0%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)1.69%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 14.43
Fwd PE 20.13
P/S 0.28
P/FCF 14.17
P/OCF 11.79
P/B 1.9
P/tB 4.79
EV/EBITDA 9.7
EPS(TTM)19.85
EY6.93%
EPS(NY)14.23
Fwd EY4.97%
FCF(TTM)20.21
FCFY7.06%
OCF(TTM)24.29
OCFY8.48%
SpS1020.05
BVpS151.08
TBVpS59.83
PEG (NY)6.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.13%
ROE 8.64%
ROCE 7.94%
ROIC 6.01%
ROICexc 6.61%
ROICexgc 13.55%
OM 2.87%
PM (TTM) 1.28%
GM N/A
FCFM 1.98%
ROA(3y)4.8%
ROA(5y)6.13%
ROE(3y)13.67%
ROE(5y)16.75%
ROIC(3y)7.86%
ROIC(5y)8.6%
ROICexc(3y)8.87%
ROICexc(5y)9.81%
ROICexgc(3y)19.84%
ROICexgc(5y)21.44%
ROCE(3y)10.58%
ROCE(5y)11.53%
ROICexcg growth 3Y-14.61%
ROICexcg growth 5Y-10.55%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-12.53%
OM growth 3Y-13.15%
OM growth 5Y-12.08%
PM growth 3Y-33.79%
PM growth 5Y-24.48%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover2.44
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 5.16
Debt/EBITDA 2.83
Cap/Depr 54.24%
Cap/Sales 0.4%
Interest Coverage 5.64
Cash Conversion 65.98%
Profit Quality 154.76%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.79%
ROIC/WACC0.77
Cap/Depr(3y)100.48%
Cap/Depr(5y)128.5%
Cap/Sales(3y)0.88%
Cap/Sales(5y)1.09%
Profit Quality(3y)147.09%
Profit Quality(5y)122.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-7.76%
EPS 5Y-1.92%
EPS Q2Q%-9.91%
EPS Next Y2.09%
EPS Next 2Y-6.25%
EPS Next 3Y10.57%
EPS Next 5Y16.81%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y12.34%
Revenue growth 5Y12.66%
Sales Q2Q%10.24%
Revenue Next Year8.3%
Revenue Next 2Y5.57%
Revenue Next 3Y6.28%
Revenue Next 5Y7.89%
EBIT growth 1Y-8.8%
EBIT growth 3Y-2.43%
EBIT growth 5Y-0.95%
EBIT Next Year33.61%
EBIT Next 3Y15.01%
EBIT Next 5Y14.4%
FCF growth 1Y-79.94%
FCF growth 3Y36.22%
FCF growth 5Y-12.07%
OCF growth 1Y-77.77%
OCF growth 3Y9.45%
OCF growth 5Y-10.91%